Mounjaro weight loss drug shows 'game-changing' UK results
A landmark study presented in Vienna shows the diabetes drug tirzepatide (Mounjaro) leads to unprecedented weight loss in NHS patients, offering new hope in the fight against obesity.
A landmark study presented in Vienna shows the diabetes drug tirzepatide (Mounjaro) leads to unprecedented weight loss in NHS patients, offering new hope in the fight against obesity.
The NHS is rolling out a powerful new 4mg weekly injection of semaglutide, a 'game-changer' in weight loss treatment, as part of a major strategy to tackle the nation's obesity epidemic.
Jeremy Clarkson's chaotic National Television Awards speech saw him joke about his trousers falling down after a two-stone weight loss on Mounjaro, while forgetting to thank partner Lisa Hogan, creating a memorable and slightly awkward moment.
UK travellers using Ozempic, Wegovy, or Mounjaro face a critical insurance loophole. Experts reveal how these popular weight-loss and diabetes injections could leave you unprotected and facing massive medical bills abroad.
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Eli Lilly deals a major blow to UK Mounjaro users, announcing a smaller KwikPen, the removal of a key 12.5mg dose, and a staggering 170% price increase, sparking outrage and access fears.
Exclusive: Desperate UK diabetics face a devastating health crisis as they are cut off from the 'miracle' weight-loss drug Mounjaro (tirzepatide) due to soaring costs and an NHS postcode lottery, with patients fearing for their lives.
A British mother's life-changing journey from 30st to 8st using diabetes drug Mounjaro. Discover how this remarkable transformation saved her marriage and restored her health against all odds.
A groundbreaking new weight loss pill from Eli Lilly, orforglipron, has demonstrated remarkable results in a UK trial, offering a potential oral alternative to injectable treatments like Mounjaro for combating obesity.
A new oral weight loss medication, Orforglipron, shows transformative potential in UK clinical trials, matching the efficacy of injectable treatments like Mounjaro and offering new hope for tackling obesity.
Exclusive: The NHS is now prescribing powerful diabetes medications Ozempic and Mounjaro for weight loss, sparking a massive surge in demand and a fierce debate over ethics and supply.
An NHS administrator reveals how she lost four stone using a controversial cost-cutting method to obtain diabetes drug Mounjaro for weight loss, as doctors issue serious safety warnings.
The NHS in England is set to provide the highly effective Mounjaro (tirzepatide) weight-loss injection, hailed as a major breakthrough in fighting obesity and related diseases like type 2 diabetes.
Shocking new data reveals a stark postcode lottery for the diabetes and weight loss drug Mounjaro (tirzepatide) in England, with patients in some areas almost completely unable to access it on the NHS despite being eligible.
The NHS in England is set to provide the weight-loss drug Mounjaro (tirzepatide) to thousands, following a landmark deal that could save millions and free up GP capacity.
Exclusive investigation reveals the staggering postcode lottery and soaring costs of life-changing obesity drugs like Mounjaro and Wegovy, as the NHS struggles to cope with unprecedented demand.
A nationwide manhunt is underway for a woman allegedly selling fake diabetes and weight-loss medications online. Authorities warn of severe health risks from counterfeit semaglutide injections.
UK health officials issue an urgent alert as a woman is hunted for selling counterfeit Mounjaro weight-loss injections online, posing a severe risk to public safety.
Groundbreaking UK study reveals a new diabetes medication, Mounjaro (tirzepatide), achieves significantly greater weight loss and superior cardiovascular benefits compared to Ozempic, revolutionising obesity treatment.
ITV's Dr Amir Khan reveals his four-stone transformation using diabetes drug Mounjaro, sparking a fierce debate among Lorraine viewers about medical ethics and weight loss solutions.
A groundbreaking UK study reveals the diabetes drug Mounjaro (tirzepatide) isn't just for weight loss—it dramatically cuts the risk of heart attacks and strokes, heralding a new era in preventative medicine.
Groundbreaking British research warns that popular weight-loss injections like Ozempic and Mounjaro may significantly increase hospitalisation risks for heart failure patients. Experts call for urgent review of prescription guidelines.
Ex-Culture Minister Ed Vaizey urges the NHS to widely prescribe revolutionary weight loss injections, calling them a potential 'miracle' for public health and a solution to the obesity crisis.
Exclusive: Medical experts warn of a deepening postcode lottery and a surge in the illegal black market for weight-loss jabs as NHS England struggles with supply and soaring demand for GLP-1 drugs.
Groundbreaking UK research finds semaglutide-based drugs, popular for weight loss, significantly improve symptoms and physical limitations in obese heart failure patients, offering a new potential treatment avenue.
Supermarket giant Asda has dramatically cut the price of the sought-after weight loss drug Mounjaro, making the weekly injection more affordable for Brits seeking treatment.
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.
The MHRA has officially approved the weight-loss injection Mounjaro (tirzepatide) for the UK market, with a set price, marking a significant new option in the nation's battle against obesity.
The UK cost of the revolutionary Mounjaro weight loss injection has been unveiled. Discover the price, availability, and how it compares to NHS prescriptions and private clinics.
Exclusive: A perfect storm of NHS price hikes and soaring demand for the 'miracle' drug tirzepatide triggers a national shortage, leaving thousands of diabetics and weight-loss patients in limbo. Fears grow as stockpiling begins.